Chrabańska Magdalena, Środa Magdalena, Kiczmer Paweł, Drozdzowska Bogna
Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze Medical University of Silesia, Katowice, Poland.
J Cytol. 2020 Jul-Sep;37(3):117-121. doi: 10.4103/JOC.JOC_168_19. Epub 2020 Jun 30.
Diagnosis of lung cancer can be made in two ways: histopathological and cytopathological. Cytological methods in the diagnosis of lung lesions are generally thought to be one of the most successful tactics.
This study aimed at comparing the efficiency of selected cytological techniques in lung lesions by correlating them with histopathological diagnosis. In addition, we had answered the question whether any of the cytological methods can replace histopathology.
The study group consisted of 633 patients and 1085 cytological specimens. Cytology samples included: induced sputum, bronchial washing (BW), bronchial brushing (BB), fine needle aspiration (FNA), and cell block (CB). In every case of CB immunocytochemistry (ICC) was performed. For each cytological method sensitivity, specificity, effectiveness, positive predictive value, and negative predictive value were assessed.
BW and BB showed the lowest diagnostic parameters. The most valuable diagnostic procedure was CB based on FNA. Close by CB, FNA had the highest diagnostic rate. However, possibility to evaluate tumor cell structure and apply the ICC, give CB an advantage over FNA. Using only morphologic criteria, we had subclassified nonsmall-cell lung cancer (NSCLC) into squamous cell carcinoma (SCC) and adenocarcinoma (AC) as 60.04% of SCC and 32.52% of AC. The use of CB and ICC decreased the NSCLC diagnoses from 22.1% to 2.8% while the percentage of AC and SCC diagnoses increased from 4.11% to 12.64% and from 6.64% to 11.06%, respectively. Metastatic lung tumors were diagnosed based on both the cell morphology and according to the ICC results.
Despite the limitations of the cytological procedures, we recommend using CB and ICC to evaluate cytological samples derived from FNA. It can in many cases replace a conventional histopathology.
肺癌的诊断可通过两种方式进行:组织病理学诊断和细胞病理学诊断。肺部病变诊断中的细胞学方法通常被认为是最成功的策略之一。
本研究旨在通过将所选细胞学技术与组织病理学诊断相关联,比较其在肺部病变中的诊断效率。此外,我们还回答了是否有任何细胞学方法可以取代组织病理学的问题。
研究组包括633例患者和1085份细胞学标本。细胞学样本包括:诱导痰、支气管冲洗液(BW)、支气管刷检(BB)、细针穿刺抽吸(FNA)和细胞块(CB)。对每个细胞块病例均进行免疫细胞化学(ICC)检测。评估了每种细胞学方法的敏感性、特异性、有效性、阳性预测值和阴性预测值。
BW和BB的诊断参数最低。最有价值的诊断方法是基于FNA的CB。紧随CB之后,FNA的诊断率最高。然而,由于能够评估肿瘤细胞结构并应用ICC,CB比FNA更具优势。仅使用形态学标准,我们将非小细胞肺癌(NSCLC)分为鳞状细胞癌(SCC)和腺癌(AC),其中SCC占60.04%,AC占32.52%。使用CB和ICC后,NSCLC的诊断率从22.1%降至2.8%,而AC和SCC的诊断百分比分别从4.11%增至12.64%和从6.64%增至11.06%。转移性肺肿瘤根据细胞形态和ICC结果进行诊断。
尽管细胞学检查存在局限性,但我们建议使用CB和ICC来评估源自FNA的细胞学样本。在许多情况下,它可以取代传统的组织病理学检查。